Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

Similar articles for PubMed (Select 8702914)

1.

Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.

Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K.

J Biol Chem. 1996 Aug 30;271(35):21345-52.

2.

[Identification of receptors for bone morphogenetic proteins].

Nishitoh H.

Kokubyo Gakkai Zasshi. 1997 Mar;64(1):24-37. Japanese.

PMID:
9125848
3.

Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.

Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T.

J Cell Sci. 1999 Oct;112 ( Pt 20):3519-27.

4.
5.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
6.

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.

Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K.

J Cell Biol. 1995 Jul;130(1):217-26.

7.

A single residue of GDF-5 defines binding specificity to BMP receptor IB.

Nickel J, Kotzsch A, Sebald W, Mueller TD.

J Mol Biol. 2005 Jun 24;349(5):933-47. Epub 2005 Apr 22.

PMID:
15890363
8.

Bone morphogenetic proteins and growth and differentiation factors in the human cornea.

You L, Kruse FE, Pohl J, Völcker HE.

Invest Ophthalmol Vis Sci. 1999 Feb;40(2):296-311.

PMID:
9950587
9.

Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.

Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.

J Biol Chem. 1997 Aug 22;272(34):21187-94.

10.

A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.

Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T.

J Biol Chem. 1997 Aug 29;272(35):22046-52.

11.
12.

Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.

Erlacher L, McCartney J, Piek E, ten Dijke P, Yanagishita M, Oppermann H, Luyten FP.

J Bone Miner Res. 1998 Mar;13(3):383-92.

PMID:
9525338
13.

The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.

Nickel J, Dreyer MK, Kirsch T, Sebald W.

J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S7-14. Review.

PMID:
11263668
14.

Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.

Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T.

Exp Cell Res. 1997 Sep 15;235(2):362-9.

PMID:
9299160
15.

Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.

Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K.

J Cell Sci. 2001 Apr;114(Pt 8):1483-9.

16.
17.

Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632-6.

18.
19.

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.

Weber D, Kotzsch A, Nickel J, Harth S, Seher A, Mueller U, Sebald W, Mueller TD.

BMC Struct Biol. 2007 Feb 12;7:6.

20.

Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.

Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P, Sakou T.

Am J Pathol. 1997 Apr;150(4):1335-47.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk